Environmental induction of the fetal epigenome

Expert Review of Obstetrics and Gynecology

Volumn 5, Issue 6, 2010, Pages 657-664

  Odom, Lawrence N ^a   Taylor, Hugh S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Barker hypothesis; bisphenol A; diethylstilbestrol; epigenetics; folic acid; lead exposure; prenatal counseling; tobacco use

Indexed keywords

DIETHYLSTILBESTROL; DINUCLEOTIDE; DNA METHYLTRANSFERASE; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; FOLIC ACID; HISTONE;

CARDIOVASCULAR DISEASE; CHILD DEATH; CHILDHOOD DISEASE; CIGARETTE SMOKING; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DNA SYNTHESIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL IMPACT; EPIGENETICS; FETUS; FETUS DEVELOPMENT; GENE; GENETIC COUNSELING; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HOXA10 GENE; HUMAN; HUMAN GENOME; HYPERTENSION; MATERNAL NUTRITION; NEURAL TUBE DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PATIENT COUNSELING; PHENOTYPE; PREGNANCY OUTCOME; PREMATURE LABOR; PROTEIN MODIFICATION; RECOMMENDED DRUG DOSE; REVIEW; SMALL FOR DATE INFANT; SMOKING CESSATION; UNITED STATES;

EID: 78249248969     PISSN: 17474108     EISSN: None     Source Type: Journal    
DOI: 10.1586/eog.10.58     Document Type: Review

References (82)

1. Barker DJ. The origins of the developmental origins theory. J. Intern. Med. 261(5), 412-417 (2007).
2. Barker DJ, Osomond C. Infant mortality, childhood nutrition and ischaemic heart disease in England and Wales. Lancet 1(8489), 1077-1081 (1986). •• First study suggesting a link between environmental exposure in utero and adult disease.
3. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 2(8663), 577-580 (1989).
4. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 341(8850), 938-941 (1993).
5. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 27, 363-388 (2007).
6. Waddington C. Organisers and Genes. Cambridge University Press, Cambridge, UK (1940).
7. Murrell A, Rakyan VK, Beck S. From genome to epigenome. Hum. Mol. Genet. 14 (Suppl. 1), R3-R10 (2005).
8. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 23(7), 781-783 (2009).
9. Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science 187(4173), 226-232 (1975). •• First study to suggest DNA methylation as an epigenetic mechanism.
10. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6), 915-926 (1992).
11. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74(1), 481-514 (2005).
12. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 293(5532), 1089-1093 (2001).
13. Morgan HD, Santos F, Green K, Dean W, Reik W Epigenetic reprogramming in mammals. Hum. Mol. Genet. 14 (Suppl. 1), R47-R58 (2005).
14. Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. Demethylation of the zygotic paternal genome. Nature 403(6769), 501-502 (2000).
15. Bestor TH. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9(16), 2395-2402 (2000).
16. Yoder JA, Soman NS, Verdine GL, Bestor TH. DNA (cytosine-5)- methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol. 270(3), 385-395 (1997).
17. Okano M, Bell DW, Haber DW, Li E. DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
18. Bird A P, Wolffe A P. Methylation-induced repression - belts, braces, and chromatin. Cell 99(5), 451-454 (1999).
19. Quina AS, Buschbeck M, Di Croce L. Chromatin structure and epigenetics. Biochem. Pharmacol. 72(11), 1563-1569 (2006).
20. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98(3), 285-294 (1999).
21. Felsenfeld G, Groudine M. Controlling the double helix. Nature 421(6921), 448-453 (2003).
22. Cheung P, Lau P. Epigenetic regulation by histone methylation and histone variants. Mol. Endocrinol. 19(3), 563-573 (2005).
23. Bateson P, Barker D, Clutton-Brock T et al. Developmental plasticity and human health. Nature 430(6998), 419-421 (2004).
24. Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am. J. Clin. Nutr. 71 (Suppl. 5), 1344S-1352S (2000).
25. Morrison AG, Callanan JJ, Evans NP, Aldridge TC, Sweeney T. Effects of endocrine disrupting compounds on the pathology and oestrogen receptor α and β distribution in the uterus and cervix of ewe lambs. Domest. Anim. Endocrinol. 25(4), 329-343 (2003).
26. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrinedisrupting chemicals in wildlife and humans. Environ. Health. Perspect. 101(5), 378-384 (1993).
27. Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J, McLachlan JA. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 21(7), 1355-1363 (2000).
28. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284(15), 878-881 (1971).
29. Block K, Kardana A, Igarashi P, Taylor HS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing Müllerian system. FASEB J. 14(9), 1101-1108 (2000).
30. Bromer JG, Wu J, Zhou Y, Taylor HS. Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 150(7), 3376-3382 (2009). •• Presented hypermethylation as a novel mechanism of diethylstilbestrol-induced altered developmental programming.
31. Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol. Reprod. 57(6), 1338-1345 (1997).
32. Gendron RL, Paradis H, Hsieh-Li HM, Lee DW, Potter SS, Markoff E. Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol. Reprod. 56(5), 1097-1105 (1997).
33. Hsieh-Li HM, Witte DP, Weinstein M et al. Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development 121(5), 1373-1385 (1995).
34. Mortlock DP, Innis JW Mutation of Hoxa13 in hand-foot-genital syndrome. Nat. Genet. 15(2), 179-180 (1997).
35. Warot X, Fromental-Ramain C, Fraulob V, Chambon P, Dollé P. Gene dosagedependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124(23), 4781-4791 (1997).
36. Bagot CN, Troy PJ, Taylor HS. Alteration of maternal Hoxa 10 expression by in vivo gene transfection affects implantation. Gene Ther. 7(16), 1378-1384 (2000).
37. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122(9), 2687-2696 (1996).
38. Satokata I, Benson G, Maas R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 374(6521), 460-463 (1995).
39. Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J. Clin. Invest. 101(7), 1379-1384 (1998).
40. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod. Toxicol. 23(3), 297-307 (2007).
41. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 113(4), 391-395 (2005).
42. Mountfort KA, Kelly J, Jickells SM, Castle L. Investigations into the potential degradation of polycarbonate baby bottles during sterilization with consequent release of bisphenol A. Food Addit. Contam. 14 (6-7), 737-740 (1997).
43. Cao X, Corriveau J. Migration of bisphenol A from polycarbonate baby and water bottles into water under severe conditions. J. Agric. Food Chem. 56(15), 6378-6381 (2008).
44. Olea N, Pulgar R, Pérez P et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 104(3), 298-305 (1996).
45. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature 401(6755), 763-764 (1999).
46. Markey CM, Luque EH, Munoz de Toro M, Sonnenschein C, Soto AM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol. Reprod. 65(4), 1215-1233 (2001).
47. Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol. Cell. Endocrinol. 254-255, 179-186 (2006).
48. Takahashi O, Oishi S. Disposition of orally administered 2, 2-Bis (4-hydroxyphenyl) propane (bisphenol A) in pregnant rats and the placental transfer of fetuses. Environ. Health Perspect. 108(10), 931-935 (2000).
49. Sugiura-Ogasawara M, Ozaki Y, Sonta S, Makino T, Suzumori K. Exposure to bisphenol A is associated with recurrent miscarriage. Hum. Reprod. 20(8), 2325-2329 (2005).
50. Hiroi H, Tsutsumi O, Takeuchi T et al. Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia. Endocr. J. 51(6), 595-600 (2004).
51. Lang IA, Galloway TS, Scarlett A et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300(11), 1303-1310 (2008).
52. Smith CC, Taylor HS. Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB J. 21(1), 239-246 (2007).
53. Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J. 24(7), 2273-2280 (2010). •• Identified altered methylation as a novel mechanism of bisphenol-A-induced developmental programming.
54. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum. Dev. 82(8), 485-491 (2006).
55. Barker DJ. The fetal and infant origins of adult disease. Br. Med. J. 301(6761), 1111(1990).
56. Heijmans BT, Tobi EW, Stein AD et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105(44), 17046-17049 (2008).
57. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol. Psychiatr. 55(10), 965-970 (2004).
58. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am. J. Clin. Nutr. 69(2), 179-197 (1999).
59. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br. Med. J. (Clin. Res. Ed.) 282(6275), 1509-1511 (1981). •• First randomized controlled trial showing reduction of neural tube defects with folic acid supplementation.
60. Mathers JC. Reversal of DNA hypomethylation by folic acid supplements: possible role in colorectal cancer prevention. Gut 54(5), 579-581 (2005).
61. Chen Z, Karaplis AC, Ackerman SL et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10(5), 433-443 (2001).
62. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D et al. Periconceptional maternal folic acid use of 400 μg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 16(4), e7845 (2009)
63. U. S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U. S. Preventive Servies Task Force recommendation statement. Ann. Intern. Med. 150(9), 626-631 (2009).
64. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338(8760) 131-137 (1991).
65. CDC. Recommendations for use of folic acid to reduce the number of spina bifida cases and other neural tube defects. MM WR 41 (RR-14), 1-7 (1992).
66. CDC. Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR 53(17), 362-365 (2004).
67. CDC. Use of supplements containing folic acid among women of childbearing age - United States, 2007 MMWR 57(1), 5-8 (2008). • Report showing insufficient folic acid supplementation in women of childbearing age as well as a possible deficiency in nutritional counseling by obstetricians and gynecologists.
68. Pilsner JR, Hu H, Ettinger A et al. Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ. Health Perspect. 117(9), 1466-1471 (2009).
69. Gulson BL, Jameson CW, Mahaffey KR, Mizon KJ, Korsch MJ, Vimpani G. Pregnancy increases mobilization of lead from maternal skeleton. J. Lab. Clin. Med. 130(1), 51-62 (1997).
70. Goyer RA. Transplacental transport of lead. Environ. Health Perspect. 89, 101-105 (1990).
71. Hertz-Picciotto L. The evidence that lead increases the risk for spontaneous abortion. Am. J. Ind. Med. 38(3), 300-309 (2000).
72. Bellinger D, Leviton A, Rabinowitz M, Allred E, Needleman H, Shoenbaum S. Weight gain and maturity in fetuses exposed to low levels of lead. Environ. Res. 54(2), 151-158 (1991).
73. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic and chromium. Chem. Res. Toxicol. 21(1), 28-44 (2008).
74. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32(14), 4100-4108 (2004).
75. CDC. Adult blood lead epidemiology and surveillance - United States 2005-2007. MMWR 58(14), 365-369 (2009).
76. Cleveland LM, Minter ML, Cobb KA, Scott AA, German VF. Lead hazards for pregnant women and children: part 1: immigrants and the poor shoulder most of the burden of lead exposure in this country. Part 1 of a two-part article details how exposure happens, whom it affects, and the harm it can do. Am. J. Nurs. 108(10), 40-49 (2008).
77. Gardella C. Lead exposure in pregnancy: a review of the literature and argument for routine prenatal screening. Obstet. Gynecol. Surv. 56(4), 231-238 (2001).
78. Bryant SD. Lead-contaminated drinking waters in the public schools of Philadelphia. J. Toxicol. Clin. Toxicol. 42(3), 287-294 (2004).
79. Horner RD, Lackey CJ, Kolasa K, Warren K. Pica practices of pregnant women. J. Am. Diet. Assoc. 91(1), 34-38 (1991).
80. CDC. Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS) - United States, 31 sites, 2000-2005. MMWR 58 (SS-4), 1-29 (2009). • Report urging more aggressive counseling from obstetricians and gynecologists regarding smoking cessation before and during pregnancy.
81. Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med. 180(5), 462-467 (2009). • Study showing that tobacco use during pregnancy can result in fetal epigenetic changes through DNA methylation.
82. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst. Rev. 4, CD001055 (2004).